| ↑ | increased |
| ↓ | reduced |
| ACR | American College of Rheumatology |
| AGEs | advanced glycation end products |
| AI | adequate intake |
| ASU | avocado–soybean unsaponifiable extracts |
| BCAAs | branched-chain amino acids |
| DHA | docosahexaenoic acid |
| EFSA | European Food Safety Authority |
| EPA | eicosapentaenoic acid |
| ESCEO | European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases |
| EULAR | European Alliance of Associations for Rheumatology |
| IL-1 | interleukin 1 |
| IL-10 | interleukin 10 |
| IL-1β | interleukin-1 beta |
| IL-2 | interleukin 2 |
| INFɣ | interferon-gamma |
| Lequesne index | presence of pain, discomfort, morning stiffness |
| MMP | matrix metalloproteinases |
| MUFAs | monounsaturated fatty acids |
| N | number of patients |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| OA | osteoarthritis |
| OARSI | Osteoarthritis Research Society International |
| PUFAs | polyunsaturated fatty acids |
| RCTs | randomized controlled trials |
| RDA | Recommended Dietary Allowance |
| ROS | reactive oxygen species |
| SFAs | saturated fatty acids |
| ss | statistically significant |
| SYSADOAs | symptomatic slow-acting drugs |
| TNFα | tumor necrosis factor-alpha |
| WOMAC | Western Ontario, and McMaster University Universities Osteoarthritic Index |
| YLD | years lived with disability |